New Key Statistics Module, Z-Score and F-Score
SZSE:301301 Key Ratios
Market Cap ¥ M | 29,710.31 |
Enterprise Value ¥ M | 30,731.04 |
P/E(ttm) | 26.68 |
PE Ratio without NRI | 25.85 |
Forward PE Ratio | -- |
Price/Book | 4.05 |
Price/Sales | 5.89 |
Price/Free Cash Flow | 23.73 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.18 |
Revenue (TTM) ¥ M | 5,076.00 |
EPS (TTM) ¥ | 0.50 |
Beneish M-Score | -2.54 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 31.00 |
EV-to-EBIT | 21.40 |
EV-to-EBITDA | 21.40 |
PEG | -- |
Shares Outstanding M | 2,227.16 |
Net Margin (%) | 22.02 |
Operating Margin % | 28.14 |
Pre-tax Margin (%) | 26.18 |
Quick Ratio | 1.21 |
Current Ratio | 1.76 |
ROA % (ttm) | 11.04 |
ROE % (ttm) | 16.58 |
ROIC % (ttm) | 14.67 |
Dividend Yield % | 1.68 |
Altman Z-Score | 7.06 |
SZSE:301301 Number of Guru Trades
SZSE:301301 Volume of Guru Trades
Gurus Latest Trades with SZSE:301301
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301301 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Yili Chuannig Biotechnology Co Ltd Insider Transactions
No Available Data